Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- ‘Exploring the power of their mind’: Data may offer clues to harnessing the placebo effect Rob Volansky
-
- Rheumatology meets placebo-nocebo science: At last! Leonard H. Calabrese, DO
- Children with obesity experience worse multisystem inflammatory syndrome outcomes Sara Kellner
- CVS Caremark to replace Humira with biosimilars on national commercial formularies Rob Volansky
- Early benefit with guselkumab predicts lower psoriatic arthritis progression at 2 years Erich Martin
- FDA investigators find no safety risks when switching between biologics, biosimilars Sara Kellner
- Helping rheum patients quit smoking: ‘Even a small conversation can have a big impact’ Rob Volansky
- Holding abatacept, TNFi unnecessary for receiving COVID-19 booster Jason Laday
- Longer interval between COVID-19 vaccine doses increases antibody levels in IRD patients Rob Volansky
-
- Match Day fills 61.5% of pediatric rheumatology fellowship slots, continuing decline Justin Cooper
- Patients with ‘pseudogout’ have double the risk for fracture vs controls Jason Laday
- Satisfaction low with mandatory transition from Humira to biosimilar in New Zealand Justin Cooper
- Therapy choice in rheumatoid arthritis does not impact serious infection risk Erich Martin
- ‘Tough to say’: Complications, guarded optimism surround Medicare price negotiations Rob Volansky
- Two-week methotrexate pause helps COVID booster response without significant flares Justin Cooper
- Work disability due to inflammatory arthritis greater among lower-paid, manual jobs Erich Martin